275 related articles for article (PubMed ID: 30927586)
1. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
2. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
3. The Antiproliferative and Apoptotic Effect of a Novel Synthesized
Malebari AM; Abd Alhameed R; Almarhoon Z; Farooq M; Wadaan MAM; Sharma A; de la Torre BG; Albericio F; El-Faham A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33671801
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
7. The activity of pyrazolo[4,3-
Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
[TBL] [Abstract][Full Text] [Related]
8. Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions.
Mohareb RM; Alwan ES
Anticancer Agents Med Chem; 2020; 20(10):1209-1220. PubMed ID: 32156245
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives.
Xiang HY; Chen YH; Wang Y; Zhang X; Ding J; Meng LH; Yang CH
Bioorg Med Chem Lett; 2020 Jun; 30(12):127194. PubMed ID: 32317209
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity.
Pathak P; Shukla PK; Kumar V; Kumar A; Verma A
Inflammopharmacology; 2018 Dec; 26(6):1441-1453. PubMed ID: 29663100
[TBL] [Abstract][Full Text] [Related]
14. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5-Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan-1).
Asghar S; Hameed S; Al-Masoudi NA; Saeed B; Shtaiwi A
Chem Biodivers; 2024 May; 21(5):e202400112. PubMed ID: 38606640
[TBL] [Abstract][Full Text] [Related]
16. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
17. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Activity of s-Triazine Derivatives: A Systematic Review.
Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y
Molecules; 2023 May; 28(11):. PubMed ID: 37298753
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives.
Yaguchi S; Izumisawa Y; Sato M; Nakagane T; Koshimizu I; Sakita K; Kato M; Yoshioka K; Sakato M; Kawashima S
Biol Pharm Bull; 1997 Jun; 20(6):698-700. PubMed ID: 9212994
[TBL] [Abstract][Full Text] [Related]
20. SARs of a novel series of s-triazine compounds targeting vimentin to induce methuotic phenotype.
Zhang L; Qu Z; Wu J; Yao S; Zhang Q; Zhang T; Mo L; Yao Q; Xu Y; Chen R
Eur J Med Chem; 2021 Mar; 214():113188. PubMed ID: 33550185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]